Michael Cloonan

Verkställande Direktör på SIONNA THERAPEUTICS, INC.

Förmögenhet: 24 M $ per 2026-06-30

55 år

83 relationer

Health Technology

Consumer Services

Finance

Profil

Michael Cloonan is President, Chief Executive Officer & Director at Sionna Therapeutics, Inc. since 2021.
Mr. Cloonan is also an Advisor at RA Capital Management LP (Private Equity).
Former roles include Director at Genetix Biotherapeutics, Inc. from 2024 to 2025, Director at Certego Therapeutics, Inc., Senior Vice President-US Commercial at Biogen, Inc. from 2015 to 2017, and Chief Operating Officer at SAGE Therapeutics, Inc. from 2020 to 2021.
Education includes undergraduate studies at College of the Holy Cross (Massachusetts) and an MBA from the University of Virginia Darden School of Business.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
SIONNA THERAPEUTICS, INC. 1,21 %	2026-04-21	547 343 ( 1,21 % )	24 M $	2026-06-30

Aktiva positioner av Michael Cloonan

Företag	Position	Start
SIONNA THERAPEUTICS, INC.	Verkställande Direktör	2021-05-01
RA Capital Management LP (Private Equity) RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement.	Konsult / Rådgivare	-

Alla aktiva positioner av Michael Cloonan

Tidigare kända positioner av Michael Cloonan

Företag	Position	Slut
GENETIX BIOTHERAPEUTICS, INC.	Direktör/Styrelseledamot	2025-06-02
SAGE THERAPEUTICS, INC.	Verksamhetschef	2021-05-03
BIOGEN INC.	Företagsledare/Principal	2017-01-01

Se detaljerna i Michael Cloonans erfarenhet

Michael Cloonans utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Michael Cloonans erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	7
Biogen, Inc. Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases	Health Technology
College of the Holy Cross (Massachusetts) College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
bluebird bio, Inc. bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells	Health Technology
SAGE Therapeutics, Inc. SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders	Health Technology
University of Virginia Darden School of Business University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
RA Capital Management LP (Private Equity) RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement.	Finance
Sionna Therapeutics, Inc. Sionna Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for CF and rare diseases	Health Technology